MAP2K1 and cancer: Similarly, curcumin exhibited synergistic anti-cancer effects in malignant melanoma cells [G 361 and SKmEL-2] in spheroid and 2D cultures when used in combination with binimetinib, a MEK1/2 inhibitor, through apoptosis, necroptosis, and ROS production [44].